Routine Application of Point-of-care PCR Test to Identify and Direct Therapy for Acute Respiratory Infection in the Emergency Department Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

1,050

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
InfluenzaCOVID-19Acute Respiratory Infections (ARIs)
Interventions
DIAGNOSTIC_TEST

Point-of-care PCR testing for respiratory viruses

A nasal swab will be collected by trained research staff in full personal protective equipment (PPE) and placed into 3 mL of viral transport medium. The sample will be immediately processed and analysed in the ED using the Xpert® Xpress SARS-CoV-2/Flu/RSV test according to the manufacturer's instructions. The results of the test will be documented in the patient's paper or electronic case notes, and the clinical team will be directly informed of all results. The participant or legal guardian who signs the consent form will also be informed of the results when appropriate.

DIAGNOSTIC_TEST

Laboratory PCR testing for respiratory viruses

The ordering of test for respiratory pathogens will be decided by the treating clinical team. All tests will be performed using the standard methods of the hospital laboratory.

Trial Locations (1)

Unknown

Accident and Emergency Department, Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT06780566 - Routine Application of Point-of-care PCR Test to Identify and Direct Therapy for Acute Respiratory Infection in the Emergency Department Trial | Biotech Hunter | Biotech Hunter